RECENT DEVELOPMENTS IN THE DIAGNOSIS AND TREATMENT OF HEPATITIS: A GLOBAL PERSPECTIVE

Hepatitis, an inflammation of the liver primarily caused by viral infections, remains a major public health concern worldwide. This article reviews the current understanding of hepatitis types A to E, emphasizing their epidemiology, pathogenesis, and therapeutic approaches. We examine recent developments in diagnostic techniques, including molecular assays and imaging, as well as innovations in antiviral therapies. The introduction of direct-acting antivirals (DAAs) has significantly improved outcomes for hepatitis C patients. Global vaccination efforts have reduced the incidence of hepatitis B, though challenges remain in low-income countries. Despite progress, gaps persist in early diagnosis, access to treatment, and long-term disease monitoring. This review highlights key advancements and identifies areas where further research and investment are needed to control and eventually eliminate hepatitis as a global threat.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-21
DOI
https://doi.org/10.5281/zenodo.15478707
Primary Topic
Salivary Gland Disorders and Functions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RECENT DEVELOPMENTS IN THE DIAGNOSIS AND TREATMENT OF HEPATITIS: A GLOBAL PERSPECTIVE

Zenodo (CERN European Organization for Nuclear Research)
Salivary Gland Disorders and Functions
article

RECENT DEVELOPMENTS IN THE DIAGNOSIS AND TREATMENT OF HEPATITIS: A GLOBAL PERSPECTIVE

article en

Abstract

Hepatitis, an inflammation of the liver primarily caused by viral infections, remains a major public health concern worldwide. This article reviews the current understanding of hepatitis types A to E, emphasizing their epidemiology, pathogenesis, and therapeutic approaches. We examine recent developments in diagnostic techniques, including molecular assays and imaging, as well as innovations in antiviral therapies. The introduction of direct-acting antivirals (DAAs) has significantly improved outcomes for hepatitis C patients. Global vaccination efforts have reduced the incidence of hepatitis B, though challenges remain in low-income countries. Despite progress, gaps persist in early diagnosis, access to treatment, and long-term disease monitoring. This review highlights key advancements and identifies areas where further research and investment are needed to control and eventually eliminate hepatitis as a global threat.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 46%
Salivary Gland Disorders and Functions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.